"Quick and accurate TB diagnosis is critical to break the chain of disease transmission, thus preventing new TB infections."
Cepheid’s revolutionary Xpert® MTB/RIF test is currently available outside the U.S., marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices.
Cepheid Cares is a program to help make this revolutionary technology available to High Burden Developing Countries, where it is needed most. Cepheid has partnered with key non-profit organizations to provide special program pricing for both the GeneXpert® System and Xpert MTB/RIF test cartridges.
Qualifying organizations should meet the following criteria:
|Governments or Government-funded Institutions such as Ministry of Health, National or Regional MTB centers, associated hospitals, armed forces, prison services.|
|Non-Government Organizations and UN related organizations working for or in those countries such as International Office of Migration (IOM) and United Nations High Commissioner for Refugees (UNHCR)|
|Not-for-profit welfare organizations helping those countries with better diagnostics such as Médecins Sans Frontières, and other humanitarian organizations such as UNICEF, Save-the-Children and the International Committee for the Red Cross (ICRC)|
|Donor agencies such as UNITAID, PEPFAR, USAID, Global Fund, etc. and Government agencies based outside the country but who are supporting implementation locally such as the CDC (USA) and Oxfam (UK)|
|Not-for-profit private organizations whose mission is in line with humanitarian principles such as private charities and/or private non-for-profit hospitals and clinics.|
If you are falling under one of these categories, please fill out our short form in the Contact Us section in order for us to follow-up with your specific needs.
To see the full list of qualifying countries, please click here.